Ranitidine Injection USP (2020-08-27)

Starting date:
August 27, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73829

Last updated:

Summary

  • Product: Ranitidine Injection USP

Reason

The affected lots may contain particles.

Depth of distribution

Healthcare establishments

Affected products

Ranitidine Injection USP

DIN, NPN, DIN-HIM

DIN 02256711

Dosage form

Solution

Strength

Ranitidine (Ranitidine Hydrochloride) 25 mg/mL

Lot or serial number

JX9941
JS7049
JN6154
JV4206
JV0519
JS1506
JP1270

Companies

Recalling Firm
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA